Effectiveness of hepatitis A vaccination among people living with HIV in Taiwan: Is one dose enough?

Effectiveness of hepatitis A vaccination among people living with HIV in Taiwan: Is one dose enough?

Background: Single dose hepatitis A virus (HAV) vaccine had been proven its efficacy in immunocompetent but not immunocompromised hosts. We aim to investigate the effectiveness of one dose versus 2 doses HAV vaccine among people living with HIV (PLHIV). Method: We conducted a 1:1 single center retro...

Full description

Bibliographic Details
Main Authors:	Pei-Hsuan Tsai, Mao-Song Tsai, Ying-Hsuan Chiang, Chung-Yu Shih, Chia-Ying Liu, Yu-Chung Chuang, Chia-Jui Yang
Format:	Article
Language:	English
Published:	Elsevier 2022-02-01
Series:	Journal of Microbiology, Immunology and Infection
Subjects:	Acute hepatitis A Immunization Immunogenicity Human immunodeficiency virus
Online Access:	http://www.sciencedirect.com/science/article/pii/S1684118220301559

Similar Items

Hepatitis D virus infections among injecting drug users with and without human immunodeficiency virus infection in Taiwan
by: Meng-Hsuan Hsieh, et al.
Published: (2016-10-01)

Stress, needs, and quality of life of people living with human immunodeficiency virus/AIDS in Taiwan
by: Ming-Chu Feng, et al.
Published: (2015-09-01)

Anti-HIV seropositivity was related to HBsAg seropositivity among injecting drug users in Taiwan
by: Meng-Hsuan Hsieh, et al.
Published: (2016-02-01)

Seroprevalence of Viral Hepatitis and Sexually Transmitted Disease Among Adults with Recently Diagnosed HIV Infection in Southern Taiwan, 2000–2005: Upsurge in Hepatitis C Virus Infections Among Injection Drug Users
by: Hsin-Chun Lee, et al.
Published: (2008-05-01)

Modeling long-term persistence after 8 years of hepatitis B booster vaccination in 5- to 15-year-old children
by: Yan Qiu, et al.
Published: (2022-11-01)

Impact of Obesity and Being Overweight on the Immunogenicity to Live Attenuated Hepatitis A Vaccine in Children and Young Adults
by: Termpong Dumrisilp, et al.
Published: (2021-02-01)

Review of long term immunogenicity and tolerability of live hepatitis A vaccine
by: Nitin Shah, et al.
Published: (2020-11-01)

Association between gallbladder stones and chronic hepatitis C: Ultrasonographic survey in a hepatitis C and B hyperendemic township in Taiwan
by: Chia-Yen Dai, et al.
Published: (2013-08-01)

Influences of obesity on the immunogenicity of Hepatitis B vaccine
by: Fang Liu, et al.
Published: (2017-05-01)

Evaluación de la inmunogenicidad de una vacuna recombinante antivirus hepatitis B en mujeres adultas sanas, Santafé de Bogotá, D.C., julio 1997 - noviembre 1998
by: María T. Herrera Mendoza, et al.
Published: (1999-06-01)

Drug-induced liver injury by glecaprevir/pibrentasvir treatment for chronic hepatitis C infection: a systematic review and meta-analysis
by: Hsuan-Yu Hung, et al.
Published: (2022-12-01)

Hepatitis A vaccination
by: Li Zhang
Published: (2020-07-01)

Hepatitis Flares or Hepatic Decompensation after Discontinuation of Tenofovir Disoproxil Fumarate and Entecavir in Non-Cirrhotic Hepatitis B e Antigen-Negative Patients
by: Yi-Jie Huang, et al.
Published: (2023-12-01)

Viral Hepatitis A, B and C in a Group of Transgender Women in Central Brazil
by: Lucila Pessuti Ferri, et al.
Published: (2022-09-01)

Safety and Immunogenicity of Inactivated COVID-19 Vaccines Among People Living with HIV in China
by: Han X, et al.
Published: (2022-04-01)

Durability of serologic responses to inactivated hepatitis A virus vaccination among people living with HIV following acute hepatitis A outbreak: a 5-year follow-up study
by: Kuan-Yin Lin, et al.
Published: (2023-12-01)

Hepatitis C Virus Infection And Metabolic Syndrome—A Community-Based Study in an Endemic Area of Taiwan
by: Jee-Fu Huang, et al.
Published: (2009-06-01)

Immunogenicity of Hepatitis B Vaccine among Medical Staff of Shahid Madani Hospital of Tabriz, Iran
by: Mehrdad Asghari Estiar, et al.
Published: (2014-09-01)

Immunogenicity of Hepatitis B Vaccine among Medical Staff of Shahid Madani Hospital of Tabriz, Iran
by: Mehrdad Asghari Estiar, et al.
Published: (2014-09-01)

There is no difference in hepatic fibrosis rates of patients infected with hepatitis C virus and those co-infected with HIV
by: A.R. Souza, et al.
Published: (2008-03-01)

Immunogenicity and safety of high-dose hepatitis B vaccine among drug users: A randomized, open-labeled, blank-controlled trial
by: Yongliang Feng, et al.
Published: (2017-06-01)

Immunogenicity and safety of a live attenuated varicella vaccine co-administered with inactive hepatitis A vaccine: A phase 4, single-center, randomized, controlled trial
by: Dapeng Sun, et al.
Published: (2023-01-01)

Gender Difference in the Clinical and Behavioral Characteristics of Human Immunodeficiency Virus-infected Injection Drug Users in Taiwan
by: Shu-Hsing Cheng, et al.
Published: (2007-01-01)

Hepatitis autoinmune como complicación de inmunodeficiencia común variable
by: Patrícia de-Oliveira-Queirós, et al.

Long-term persistence of anti-HBs after hepatitis B vaccination among adults: 8-year results
by: Wen Ren, et al.
Published: (2020-03-01)

Genetic Susceptibility to Hepatocellular Carcinoma in Patients with Chronic Hepatitis Virus Infection
by: Tsai-Hsuan Yang, et al.
Published: (2023-02-01)

Association of Hepatitis B and C Virus with the Risk of Coronary Artery Disease and Cerebrovascular Disease in Patients with Hepatocellular Carcinoma
by: Meng-Chuan Lu, et al.
Published: (2023-03-01)

Absence of chronic hepatitis E in a German cohort of common variable immunodeficiency patients
by: Sven Pischke, et al.
Published: (2012-05-01)

Estimation of Seroprevalence of Hepatitis B Virus and Hepatitis C Virus in Taiwan from a Large-scale Survey of Free Hepatitis Screening Participants
by: Chien-Hung Chen, et al.
Published: (2007-01-01)

Investigating the effect of serum level of uric acid on the immunogenicity of hepatitis B vaccination in dialysis patients
by: Nasibe Golestani, et al.
Published: (2024-04-01)

Recombinant Hepatitis B Vaccine Adjuvanted With AS04 in Dialysis Patients: A Prospective Cohort Study
by: Fabrizio Fabrizi, et al.
Published: (2015-11-01)

Delays in Hepatitis A vaccination in people with HIV in Houston, Texas between 2010 and 2018
by: Emily T. Ciocca, et al.
Published: (2024-01-01)

Viral Hepatitis Infections in Southern Taiwan: A Multicenter Community-based Study
by: Jeng-Fu Yang, et al.
Published: (2010-09-01)

Immunogenicity persistence in children of hepatitis A vaccines Healive® and Havrix®: 11 years follow-up and long-term prediction
by: Yongji Wang, et al.
Published: (2020-10-01)

The immunogenicity and safety of GSK’s recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience
by: Caroline Van Den Ende, et al.
Published: (2017-08-01)

Prevalence of hepatitis B in people living with HIV/AIDS in Latin America and the Caribbean: a systematic review and meta-analysis
by: Fatima Mitiko Tengan, et al.
Published: (2017-08-01)

Risk of Non-Hodgkin Lymphoma among Patients with Hepatitis B Virus and Hepatitis C Virus in Taiwan: A Nationwide Cohort Study
by: Yung-Rung Lai, et al.
Published: (2022-01-01)

Hepatitis C treatment outcome in relation to alcohol consumption and racial differences in southeastern Taiwan
by: Ching-Chung Lin, et al.
Published: (2015-11-01)

Occult hepatitis B virus infection among human immunodeficiency virus-infected patients with isolated hepatitis B core antibody in Isfahan, Iran
by: Farzin Khorvash, et al.
Published: (2014-01-01)

Higher rate of long-term serologic response of four double doses vs. standard doses of hepatitis B vaccination in HIV-infected adults: 4-year follow-up of a randomised controlled trial
by: Romanee Chaiwarith, et al.
Published: (2019-11-01)